Tuyển tập các báo cáo nghiên cứu về sinh học được đăng trên tạp chí hóa học quốc tế đề tài : Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer | Pickard et al. Health and Quality of Life Outcomes 2010 8 4 http content 8 1 4 HEALTH AND QUALITY of life outcomes CORRECTION Open Access Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer A Simon Pickard 1 Maureen P Neary2 David Celia3 Correction We wish to correct a mistake in the abstract and conclusion of our published paper 1 . In the abstract and conclusion the MID for EQ-VAS score should be reported as 7 rather than . EQ-VAS scores range from 0 to 100 while EQ-5D index-based scores are anchored by 0 dead and 1 perfect health . The specific wording in the conclusion of the abstract should read Important differences in EQ-5D utility and VAS scores were similar for all cancers and lung cancer with the lower end of the range of estimates closer to the MID i. e. for UK-index scores for US-index scores and 7 for VAS scores. Author details 1Center for Pharmacoeconomic Research Department of Pharmacy Practice College of Pharmacy University of Illinois at Chicago Chicago USA. 2Global Health Outcomes GlaxoSmithKline Collegeville Pennsylvania USA. 3Center for Outcomes Research and Education Evanston Healthcare and Feinberg Schoolof Medicine Northwestern University Chicago USA. Received 30 December 2009 Accepted 13 January 2010 Published 13 January 2010 References 1. Pickard AS Neary MP Cella D Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes 2007 5 70. doi 1477-7525-8-4 Cite this article as Pickard et al. Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health and Quality of Life Outcomes 2010 8 4. Correspondence pickard1@ 1Center for Pharmacoeconomic Research Department of Pharmacy Practice College of Pharmacy University of Illinois at Chicago Chicago USA BioMed Central Publish with BioMed Central and every scientist can read your work free of charge BioMed Central will be the most .
